Características clínicas y fisiológicas del síndrome de Hellp

Jimena Bracamonte-Peniche, Vanesa López-Bolio, María del Mar Mendicuti-Carrillo, José María Ponce-Puerto, María José Sanabrais-López, Nina Mendez-Dominguez

Resumen

RESUMEN

El síndrome de HELLP es una complicación multisistémica del embarazo que se distingue por el trastorno hipertensivo más la triada: hemólisis microangiopática, elevación de enzimas hepáticas y disminución del conteo de plaquetas. Está asociado con la aparición de graves complicaciones perinatales e incremento de la mortalidad materna. Ocurre en 0,5 a 0,9% de todos los embarazos y en 10 a 20% de las pacientes con preeclampsia-eclampsia. Complicaciones obstétricas como ésta deben sospecharse de manera temprana para poderlas atender de manera oportuna y así prevenir situaciones potencialmente fatales tanto para la madre como para el feto. Es por ello, que deben integrarse adecuadamente los signos y síntomas, comprendiendo el reto diagnóstico que este síndrome puede significar.

ABSTRACT
HELLP syndrome is a severe systemic complication in pregnancy characterized by hypertensive disorder added to the clinical profile that includes: microangiopathic hemolysis, elevation of liver enzymes, and decreased platelet count. It is associated with the appearance of serious perinatal complications and increased maternal mortality. It occurs in 0.5 to 0.9% of all pregnancies and in 10 to 20% of patients with pre-eclampsia/eclampsia. Obstetric complications such as this syndrome need to be suspected in clinical practice, to prevent fatal outcomes for both, the mother and the fetus. Therefore, clinical manifestations should be identified early to approach challenges that the diagnosis may pose.  

 

Texto completo:

PDF HTML

Referencias

Homero C, Alatorre J, Cantú O, Gómez D, 2012. Síndrome de Hellp, diagnóstico y tratamiento. Rev Hematol Mex;13(4):195-200.

Miranda M, Vallejo A, Cerrillo L, Marenco M, Villar J, Stiefel P, 2017. The HELLP syndrome (hemolysis, elevated liver enzymes and low platelets): Clinical characteristics and maternal–fetal outcome in 172 patients. Pregnancy hypertens;1(2):164-169.

Parra P, Beckles M, 2005. Diagnóstico y Manejo Oportuno del Síndrome de HELLP. Acta méd;47(1):07-14.

Rivas E, Mendivil C, 2011. Síndrome de Hellp: Revisión.Rev Salud Uninorte; 27(2): 259-274.

Núñez D, 2013. Síndrome de Hellp. Rev Méd Costa Rica Centroamérica; 70(606):203-27.4.

Weinstein L, 2005. It has been a great ride: the history of HELLP syndrome. Am J Obstet Gynecol.193(3 Pt 1):860–863.

López J, Rivs M, Colmenares B, Alvarado S, Silva D, Capretta D, 2001. Síndrome HELLP en la Maternidad del Hospital Dr. Adolfo Prince Lara. Rev Obstet Ginecol Venez ;61(2):77-81.

De la Rubia, J, 2001. Síndrome HELLP. Med Clin;117:64-68.

Castillo, D, 2007. Síndrome HELLP: Actualización. Rev Cubana Hematol Inmunol Hemoter;23(1).

Sibai, B, 1999. HELLP Syndrome. Clin Obstet Gynecol;42:381-389.

Collinet P, Jourdian M, 2007. Le HELLP syndrome. Réanimation;16:386-392.

Rivas E, Mendivil C, 2011. Síndrome de Hellp: Revisión. Rev Salud Uninorte;27(2):259-274.

Carputo R, 2013. Fisiopatología de la preeclampsia. ¿Es posible prevenirla?. Hospital Universitario Virgen De Las Nieves

Cuffe J, Holland O, Salomon C, Rice G, Perkins A, 2017. Review: Placental derived biomarkers of pregnancy disorders. Placenta;54:104-110.

Pan Q, Niu H, Cheng L, Li X, Zhang Q, Ning Y, 2017. Invasion of trophoblast cell lines is inhibited by miR-93 via MMP-2. Placenta;53:48-53.

Giachini F, Galaviz C, Damiano A, Viana M, Cadavid A, Asturizaga P, et al, 2017. Vascular Dysfunction in Mother and Offspring During Preeclampsia:Contributions from Latin-American Countries. Curr Hypertens Rep;19(10):83.

Burton G, Woods A, Jauniaux E, Kingdom J, 2009. Rheological and Physiological Consequences of Conversion of the Maternal Spiral Arteries for Uteroplacental Blood Flow during Human Pregnancy. Placenta;30(6):473-82.

Muñoz M, 2016. Manual CTO de medicina y cirugía. 2da ed. México: Grupo CTO.

Doshi S, Zucker SD, 2003. Liver emergencies during pregnancy. Gastroenterol Clin North Am;32:1213–1227.

Barton J, Riely C, Adamec T, Shanklin D, Khoury A, Sibai B, 1992. Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome. Am J Obstet Gynecol;167:1538-1543.

Burrow G, 1999. Medical Complication During Pregnancy. 5o edición. EEUU: Saunders; 212.

Knapen M, 1998. Liver function following pregnancy complicated by the HELLP syndrome. Br J Obstet Gynecol;105(11):1208-1210.

Aloizos S, Seretis C, Liakos N, Aravosita P, Mystakelli C, Kanna E, Gourgiotis S, 2013. HELLP syndrome: Understanding and management of a pregnancy-specific disease. J Obstet Gynaecol;33(4):331–337.

Baxter JK, Weinstein L, 2004. HELLP syndrome: the state of the art. Obstet Gynecol Surv;59:838-845.

Cavkaytar S, Ugurlu EN, Karaer A, Tapisiz OL, Danisman N, 2007. Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome? Acta Obstet Gynecol Scand;86: 648-651.

Kumar Yadav D, Kumar Shah A, 2017. HELLP Syndrome: A brief review. Journal of Biomedical and Pharmaceutical Research;6(2):86-91.

Vigil-DeGracia P, 2015. Sindrome HELLP. Ginecol Obstet Mex; 83: 48-57.

Rezai S, Faye J, Hughes A, Cheung M, Cohen J, Kaia J, et al, 2017. Hemolysis, Elevated Liver Enzymes, and Low Platelets, Severe Fetal Growth Restriction, Postpartum Subarachnoid Hemorrhage, and Craniotomy: A Rare Case Report and Systematic Review. Case Rep Obstet Gynecol.2017.

Geary M, 1997. The HELLP syndrome. BJOG;104(8):887-891.

Ditisheim A, Sibai B. 2017. Diagnosis and Management of HELLP Syndrome Complicated by Liver Hematoma. Clin Obstet Gynecol;60(1):190-197.

Dusse L, Alpoim P, Silva J, Rios D, Brand A, Cabral C, 2015. Revisiting HELLP syndrome. Clin Chim Acta;451(Pt B):117-20.

Secretaría de Salud, 2002. Prevención, diagnóstico y manejo de la preeclampsia/eclampsia: Lineamiento Técnico.

Cararach V, Bote F, 2008. Preeclampsia. Eclampsia y síndrome HELLP. Institut Clínic de Ginecologia, Obstetrícia i Neonatologia.

Abildgaard U, Heimdal K, 2013. Pathogenesis of the syndrome of hemolysis, elevated liver enzymes, and low platelet count (HELLP): a review. Eur J Obstet Gynecol Reprod Biol; 166(2):117-23.

Sibai B, 1990. The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): Much ado about nothing? Am J Obstet Gynecol;162(2):311-316.

Martin J, Rose C, Briery C, 2006. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol;195(4):914-34

Gedik E, Yücel N, Sahin T, Koca E, Ziya Y, Togal T, 2016. Hemolysis, elevated liver enzymes, and low platelet syndrome: Outcomes for patients admitted to intensive care at tertiary referral hospital. Hypertens Pregnancy; 36(1):21-29.

Martín, J, 1999. The spectrum of severe preeclampsia: Comparative analysis by HELLP syndrome. Am J Obstet Gynecol;180(6 Pt1):1373-1384.

Zatelli M, Comai A, 2015. Spontaneous rupture of the liver in a patient admitted for subarachnoid hemorrhage. Int J Surg Case Rep;6:15–18

Llovera I, Roit Z, Johnson A, Sherman L, 2005. Cortical blindness, a rare complication of preeclampsia. J Emerg Med;29(3):295–297.

Block H, 2016. Neurological complications of pregnancy. Curr Neurol Neurosci Rep;16(7):67.

Aranas R, Prabhakaran S, Lee V, 2009. Posterior reversible encephalopathy syndrome associated with hemorrhage. Neurocrit Care;10(3):306–312.

Shah A, 2003. Non-aneurysmal primary subarachnoid hemorrhage in pregnancy-induced hypertension and eclampsia. Neurology;61(1):117-120.

Robinson J, Hall C, Sedzimir C, 1973. Subarachnoid hemorrhage in pregnancy. JNS;36(1)27-33.

Barton J, Sibai B, 2004. Diagnosis and management of hemolysis, elevated liver enzymes, and low platelets syndrome. Clin Perinatol;31(4):807-833.

Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA, 2010. Liver disease in pregnancy. Lancet;375(9714):594-605.

Katz L, de Amorim MMR, Figueiroa JN, et al, 2008. Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double- blind, placebo controlled, randomized clinical trial. Am J Obstet Gynecol;198(3):283.e1-283.e8.

Hay J, 2008. Liver Disease in Pregnancy. Hepatology;47(3):1067-1076.

Sibai BM, 2004. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol;103(5 Pt 1):981-991.

Erkurt M, Berber I, Berktas H, Kuku I, Kaya E, Koroglu M, et al, 2015. A life-saving therapy in Class I HELLP syndrome: Therapeutic plasma exchange. Transfus Apher Sci;52(2):194-198.

Mecacci F, Carignani L, Cioni R, Parretti E, Mignosa M, Piccioli A, et al, 2001. Time course of recovery and complications of HELLP syndrome with two different treatments: heparin or dexamethasone. Thromb Res;102(2):99–105.

Magann E, Bass D, Chauhan S, Sullivan D, Martin R, Martin J Jr, 1994. Antepartum corticosteroids: disease stabilization in patients with the syndrome of hemolysis, elevated liver enzymes and low platelets (HELLP). Am J Obstet Gynecol;171(4):1148–53.

Fitzpatrick K, Hinshaw K, Kurinczuk J, Knight M, 2014. Risk factors, management, and outcomes of hemolysis, elevated liver enzymes, and low platelets syndrome and elevated liver enzymes, low platelets syndrome. Obstet Gynecol;123(3):618-27.

ElFarra J, Bean C, Martin J Jr, 2016. Management of Hypertensive Crisis for the Obstetrician/Gynecologist. Obstet Gynecol Clin North Am;43(4):623-637.

Barnhart L, 2015. HELLP Syndrome and the Effects on the Neonate. Neonatal Netw;34(5):269-73.

Almuna R, Valdés L, Ramírez C, Barrera V, Bakal F, Montoya I, 2003. Eficacia de la Dexametasona en Síndrome HELLP. Rev Chil Obstet Ginecol;68(6):508-512.

Restrepo C, Márquez E, Sanz M, 2009. Plasmaféresis terapéutica, tipos, técnica e indicaciones en medicina interna. Act Med Colomb;34(1):23-32.

Rahman T, Wendon J, 2002. Severe hepatic dysfunction in pregnancy. QJ Med;95(6):343–357.

Magann EF, Martin JN Jr, 1999. Twelve steps to optimal management of HELLP syndrome. Clin Obstet Gynecol;42(3):532-550.

Habli M, Edtekhari N, Wiebracht E, et al, 2009. Long-term maternal and subsequent pregnancy outcomes 5 years after hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome. Am J Obstet Gynecol;201(4):385.e1-5.

O´Brien MJ, Barton RJ, 2005. Controversies with the diagnosis and management of HELLP syndrome. Clin Obstet Gynecol;48(2):460-477.

Sep S, Verbeek J, Koek G, et al, 2010. Clinical differences between early- onset HELLP syndrome and early- onset preeclampsia during pregnancy and at least 6 months postpartum. Am J Obstet Gynecol;202(3):271.e1-271.e5.

Ellison J, Sattar N, Greer I, 1999. HELLP syndrome: mechanisms and management. Hosp Med;60(4):243-249.

Egerman RS, Sibai BM, 1999. HELLP syndrome. Clin Obstet Gynecol;42(2):381-389.

Hupuczi P, Rigo B, Sziller I, Szabo G, Szigeti Z, Papp Z, 2006. Follow-up analysis of pregnancies complicated by HELLP syndrome. Fetal Diagn Ther;21(6):519-522.

Mallick I, Syed S, Kar A, 2007. Liver rupture following delivery: HELLP needed. Emerg Med J;24(5):372.

Pliego Pérez AR, Zavala Soto JO, Rodríguez Ballesteros R, Martínez Herrera Fde J, Porras Jiménez A, 2006. Spontaneous hepatic rupture of pregnancy. A report of four cases and medical literature review. Ginecol Obstet Mex;74(4): 224-231.

Seren G, Morel J, Jospe R, et al, 2006. HELLP syndrome and ruptured subcapsular hepatic haematoma. Case report and therapeutic options. Ann Fr Anesth Reanim;25(10):1067-1069.

Vingolo J, Vacarezza M, Álvarez C, Sosa A, 2011. Niveles de atención, de prevención y atención primaria de la salud. Arch Med Interna;(1):11-14.

Díaz L, Serrano N, 2008. Oportunidades de investigación en preeclampsia, desde la perspectiva de prevención primaria. un artículo de reflexión. Rev Colomb Obstet Ginecol;59(3):206-2015.

Enlaces refback

  • No hay ningún enlace refback.